VOGT FREDERICK G (Interim CEO & General Counsel) exercised options at IOVANCE BIOTHERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 9/4/2025ACC: 0001104659-25-087549
DirectorOfficer· Interim CEO & General Counsel
Since Mar 2026
-22.13K
Net shares
Net seller
$48.5K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
52.09K acquired · 74.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+52.09K
Price / share
—
Trade value
—
% of position
12.9%
9/2/2025
404.60K→456.69K
Common Stock
Direct
Shares
−22.13K
Price / share
$2.19
Trade value
$48.46K
% of position
4.8%
9/2/2025
456.69K→434.56K
Total
Net shares
+29.96K
Net value
-$48.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2025 | M · Option Exercise | +52.09K | — | — | 12.9% | 404.60K | 456.69K |
| Common Stock Direct | 9/2/2025 | F · Tax Withholding | −22.13K | $2.19 | $48.46K | 4.8% | 456.69K | 434.56K |
| Total | +29.96K | -$48.46K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common stock
10.42K shares
Shares
−10.42K
Strike price
Held after
20.39K
Exercisable
—
9/2/2025
Restricted Stock Units
Direct
Converts to
Common stock
41.67K shares
Shares
−41.67K
Strike price
Held after
250.01K
Exercisable
—
9/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common stock10.42K shares | 9/2/2025 | M · Option Exercise | −10.42K | — | 20.39K | |
| Restricted Stock Units Direct | Common stock41.67K shares | 9/2/2025 | M · Option Exercise | −41.67K | — | 250.01K |